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1. Introduction  
The basis of enzyme kinetic modelling was established during the early 1900’s when the 
work of Leonor Michaelis and Maud Menten produced a pseudo-steady state equation 
linking enzymatic catalytic rate to substrate concentration (Michaelis & Menten, 1913). 
Building from the Michaelis-Menten equation, other equations used to describe the effects of 
modifiers of enzymatic activity were developed based on their effect on the catalytic 
parameters of the Michaelis-Menten equation. Initially, inhibitors affecting the substrate 
affinity were deemed competitive and inhibitors affecting the reaction rate were labelled 
non-competitive (McElroy 1947). These equations have persisted as the basis for inhibition 
studies and can be found in most basic textbooks dealing with the subject of enzyme 
inhibition. Here the functionality of the competitive and non-competitive equations are 
examined to support the development of a unified equation for enzymatic activity 
modulation.  From this, a modular approach to pseudo-steady state enzyme kinetic equation 
building is examined. Finally the assumption that these equations, which stem from the 
Michaelis-Menten equation, are truly pseudo-steady state is also examined. 
2. Pseudo steady state enzyme kinetic  
2.1 Michaelis-Menten kinetics 
Conventional views on how to handle enzyme kinetic data have remained essentially the 
same for nearly a century following the proposal of the Michaelis-Menten equation (1913; 
Equation 1).  
ݒ = ௠ܸ௔௫ [ܵ][ܵ] + ܭெ (1)
The Michaelis-Menten equation was a large step forward in our ability to understand how 
biological systems control chemical processes. This equation linked the rate of enzymatic 
substrate catalysis to a mass action process relying on the fractional association between the 
substrate and the enzyme population. That is, the maximum conversion rate of substrate to 
product (Vmax) could be directly related to the concentration of the enzyme ([E]) present and 
the catalytic rate at which individual enzymes converted substrate molecules to product 
(kcat; Equation 2). 
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௠ܸ௔௫ = ݇௖௔௧[ܧ] (2)
The second part of the equation describes the fractional association between the substrate 
and the enzyme population. Dependent on the Michaelis-Menten constant (KM; Equation 3), 
this part of the Michaelis-Menten equation partitions the binding of substrate to the enzyme 
population relative to the Michaelis-Menten constant.  [ܵ][ܵ] + ܭெ (3)
At substrate concentrations lower than the Michaelis-Menten constant, also known as the 
substrate affinity constant, less than half of the enzyme population would be expected to 
have substrate associated with it (Figure 1). 
 
Fig. 1. Rectangular hyperbola plot of the Michaelis-Menten equation relating catalytic rate 
and substrate concentration.  
At a concentration equal to the Michaelis-Menten constant, half of the enzyme population 
will have substrate associated with it. Therefore, the Michaelis-Menten constant itself is an 
inflection point. As substrate concentrations exceed the Michaelis-Menten constant, the 
fraction of the enzyme population interacting with substrate is pushed towards 100%. This 
term produces the characteristic rectangular hyperbolic profile associated with the 
Michaelis-Menten equation shown above.   
2.2 Linearization of the Michaelis-Menten equation 
The introduction of the reciprocal form of the Michaelis-Menten equation (Equation 4) in 
1934 (Lineweaver & Burk) made the determination of the kinetic constants (KM, Vmax) of the 
Michaelis-Menten equation much simpler.   1ݒ = ܭெ௠ܸ௔௫ 1[ܵ] + 1௠ܸ௔௫ (4)
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The reciprocal form of the equation produced a straight line with intercept values on the Y 
axis of 1/Vmax and on the X axis of -1/KM (Figure 2). This advancement in analysis of the 
Michaelis-Menten equation allowed for a simplified way of analyzing the effect of 
compounds that altered the catalytic activity of enzyme systems. Changes in enzymatic 
activity were observed to result from changes in the substrate affinity or maximum velocity 
(Lineweaver & Burk 1934) resulting in the definition of inhibitory equations based on their 
effects on the kinetic constants of the Michaelis-Menten equation.   
 
Fig. 2. Double reciprocal plot of the Michaelis-Menten equation indicating how the 
intercepts provide a simplified way of determining the kinetic constants of the equation. 
2.3 Modes of inhibition 
By far the most extensively documented form of interactions between modifiers of 
enzymatic activity and enzymes have been inhibitory, therefore, it is not surprising that the 
first mathematical models to be defined and accepted in the literature were the competitive 
(Equation 5) and non-competitive (Equation 6) modes of inhibition (Lineweaver & Burk 
1934; McElroy 1947).  
ݒ = ௠ܸ௔௫ [ܵ][ܵ] + ܭெ ൬1 + [ܫ]ܭ௜ ൰ (5)
ݒ = ௠ܸ௔௫ [ܵ]ሺ[ܵ] + ܭெሻ ൬1 + [ܫ]ܭ௜ ൰ (6)
The competitive inhibition (Equation 5) and non-competitive inhibition (Equation 6) 
equations model different inhibitory processes and are easily identified using Lineweaver-
Burk double reciprocal plots (Figure 3).  Competitive inhibition has been defined as a direct 
1
/v
1/[S]
1/VMAX
-1/KM
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competition between the substrate and the inhibitor molecule for the active site of the 
enzyme. As inhibitor concentration is increased, the enzyme’s substrate affinity is decreased. 
However, due to the competitive nature of this interaction, decreases in catalytic activity can 
always be overcome with sufficient increases in substrate concentration. In contrast, non-
competitive inhibition exclusively affects the catalytic velocity of the enzyme population. 
Shifts in the maximum velocity can be attributed to the inhibitor binding to the enzyme and 
shutting down its catalytic activity, such that the observed decrease in activity represents 
the percent of the enzyme population bound by inhibitor. 
 
 
Fig. 3. Double reciprocal plots of a) competitive inhibition, where introduction of the 
inhibitor produces changes exclusively in the substrate affinity constant (KM) and b) non-
competitive inhibition, where inhibition is observed as a decrease in the maximum velocity 
of the enzyme catalyzed (Vmax) reaction. 
Both of the competitive and non-competitive inhibition equations can be derived from rate 
and conservation of mass equations  like the Michaelis-Menten equation. The derivation of 
the competitive (Equation 5) and non-competitive (Equation 6) inhibition equation also 
results in a similar inhibitory term (Equation 7).  
ቆ1 + [ܫ]ܭ௜ቇ (7)
This type of equation derivation, which segregates modes of inhibition based on inhibitory 
effect on kinetic constants of the Michaelis-Menten equation, has formed the basis for 
equation derivation in modern enzyme kinetics. However the use of the inhibitory term 
(Equation 7) found in the competitive (Equation 5) and non-competitive (Equation 6) 
inhibition equations may be regarded as an incomplete derivation that obscures the 
relationship between inhibitor binding and kinetic effect (Walsh et al., 2007).  
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In the competitive inhibition equation (Equation 5), the inhibitory term, as written, directly 
affects the Michaelis-Menten constant. This might be expected as competitive inhibition 
exclusively alters substrate affinity. In the non-competitive equation (Equation 6), the 
inhibitory term is inversely related to the maximum velocity (Equation 8). 
௠ܸ௔௫1 + [ܫ]ܭ௜  (8)
A rearrangement of this term (Equations 9-12) demonstrates the similarities of the inhibitory 
term and the term relating the fractional association between substrate and enzyme 
population (Equation 3). 
௠ܸ௔௫[ܫ] + ܭ௜ܭ௜  (9)
௠ܸ௔௫[ܫ] + ܭ௜[ܫ] + ܭ௜ − [ܫ]  (10)
௠ܸ௔௫11 − [ܫ][ܫ] + ܭ௜  (11)
௠ܸ௔௫ − ௠ܸ௔௫ [ܫ][ܫ] + ܭ௜ (12)
Therefore the inhibitory term of the non-competitive inhibition equation directly equates 
shutting down of enzymatic activity with the fraction of the enzyme population bound by 
the inhibitor.  This on off analog behaviour provides a simplistic way looking at enzymatic 
activity and limits the usefulness of this equation for describing anything other than 
complete inhibition of the enzyme upon inhibitor binding. However, the addition of a 
governor term (Vmax-Vmax2) changes the non-competitive term such that it can be used to 
account for changes in catalytic activity, other than complete inhibition (Equation 13; Walsh 
et al., 2007; Walsh et al., 2011a).  
௠ܸ௔௫ − ሺ ௠ܸ௔௫ − ௠ܸ௔௫ଶሻ [ܫ][ܫ] + ܭ௜ (13)
This rearrangement, or insertion of a governor term, allows for the description of inhibitory 
effects ranging from just greater than 0% to 100% and has the potential to describe activation 
as well if the secondary maximum velocity is greater than the initial velocity. It is 
convenient to classify compounds with the potential to activate as well as inhibit as 
modifiers, denote here as X (Equation 14).  
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௠ܸ௔௫ − ሺ ௠ܸ௔௫ − ௠ܸ௔௫ଶሻ [ܺ][ܺ] + ܭ௫ (14)
Even without the addition of the governor term to the non-competitive equation, this 
rearrangement (Equation 9-12) accounts for the rectangular hyperbolic change in maximum 
velocity produced by the non-competitive inhibition equation (Figure 4).  This change is 
identical to the mass action binding observed between the substrate and the enzyme 
population in the Michaelis-Menten equation (Figure 1). 
 
Fig. 4. Rectangular hyperbolic changes in the maximum velocity produced by modifiers. 
Here the mass action binding between the enzyme population and modifier results in the 
characteristic shape of the curve but the change in activity depends on the change induced 
by single binding events between the enzyme and the modifier.  For example the four lines 
represent stimulation (Vmax2 > Vmax), binding without catalytic effect (Vmax2 = Vmax), partial 
inhibition (Vmax2 = 0.5x Vmax) and complete inhibition (Vmax2 = 0) as would be observed with 
the classical non-competitive equation. 
With the clear way non-competitive inhibition mimics the kinetics observed with the 
Michaelis-Menten equation, the manner in which competitive inhibitors affect enzyme 
activity becomes obscure. This can be demonstrated through the same rearrangement of the 
inhibitory term which directly affects the substrate affinity (Equations 15-19). 
ܭெ ൬1 + [ܫ]ܭ௜ ൰ (15)
ܭெ ቆ[ܫ] + ܭ௜ܭ௜ ቇ (16)
ܭெ ቆ [ܫ] + ܭ௜[ܫ] + ܭ௜ − [ܫ]ቇ (17)
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ܭெ ൮ 11 − [ܫ][ܫ] + ܭ௜൲ (18)ܭெ1 − [ܫ][ܫ] + ܭ௜ (19)
As can be seen in equation 19, the inhibitory term in the competitive inhibition equation 
(Equation 5) actually describes a situation where the substrate affinity term is divided by the 
percent of the enzyme population free of the competitive inhibitor. This implies that modifiers 
that affect the substrate affinity exclusively produce a linear increase in the substrate affinity 
with increasing inhibitor concentration (Figure 5).  However, as substrate binding specificity 
and affinity result from three point binding (Ogston, 1948), changes in the ability of an enzyme 
to bind substrate are more likely to result from inhibitor interactions that shift the enzyme’s 
ability to do this away from its native state. Such perturbations would follow the same mass 
action mode of interaction as observed with non-competitive inhibition (Equation 6). These 
changes in substrate affinity would be finite and the overall observable effect would result 
from individual interactions between inhibitor and enzyme which would shift the binding 
affinity form that of the native enzyme (KM) to an affinity produced by the inhibitor (KM2) 
(Equation 20; Walsh et al., 2007; Walsh et al., 2011a). 
ݒ = ௠ܸ௔௫ [ܵ][ܵ] + ܭெ − ሺܭெ − ܭெଶሻ [ܫ][ܫ] + ܭ௜ (20)
While true competitive inhibition may exist, the criteria for identifying an inhibitor as truly 
competitive needs to include a linear shift in substrate affinity resulting from increase in 
inhibitor concentration (Figure 5d; Walsh et al., 2007; Walsh et al., 2011a). This should be 
examined with global data fitting to confirm the inhibitory effect on substrate affinity.  
3. Modular enzyme kinetic equation building 
3.1 Unified modifier equation 
By recognizing that changes in the substrate affinity and maximum velocity result from 
stoichiometric interactions between the modifier and the enzyme and that the effects of the 
modifier can be regulated with a governor term, a single equation for describing these 
effects can be generated (Equation 21; Walsh et al., 2007). 
ݒ = [ܵ][ܵ] + ܭௌଵ − ሺܭௌଵ − ܭௌଶሻ ൬ [ܺ][ܺ] + ܭ௑ଵ൰ ௌܸଵ − ሺ ௌܸଵ − ௌܸଶሻ ൬ [ܺ][ܺ] + ܭ௑ଵ൰ (21)
Here the maximum velocity term has been abbreviated as VS1, and the substrate affinity 
term KS1, for simplicity.  Of note, the modifier binding constant (KX1) is the same in the term 
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modifying the substrate affinity and the term modifying the maximum velocity. This is in 
contrast to the mixed non-competitive equation (Equation 22) which has been used to 
describe similar dual effects on substrate affinity and maximum velocity but requires two 
separate inhibitor binding constants to accommodate the effects of a single inhibitor.  
ݒ = ௠ܸ௔௫ [ܵ][ܵ] ൬1 + [ܫ]ߙܭ௜൰ + ܭெ ൬1 + [ܫ]ܭ௜ ൰ (22)
 
 
         
 
Fig. 5. Double reciprocal plots of the a)  competitive inhibition equation (Equation 5), 
representing a continuous change in substrate affinity with increasing inhibitor concentration, 
b) Equation 20 representing a hyperbolic change from one substrate affinity to another as the 
inhibitor binds in a stoichiometric way with the enzyme, c) an overlay of the two plots and d) a 
plot of the shift in substrate affinity at different concentrations of the inhibitor.   
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This need for two inhibitor constants and the problems associated with this notation can be 
attributed to the inverse way in which the inhibitory terms affect the kinetic constants of the 
Michaelis Menten equation, as outlines in the previous section.  
In addition to the unification of binding constants and introduction of governor terms, the 
format of Equation 21 also represents an improvement over the competitive (Equation 5), 
non-competitive (Equation 6) and mixed non-competitive (equation 22) equations. This is 
due to the structure of the modifier term in that they can be expanded in a modular format 
to include additional modifier effects.  
3.2 Modular substrate and modifier term expansion 
Cholinesterases are the prime example of enzymes that have been found to be subject to 
substrate modulation. Specifically, acetylcholinesterase is known to experience substrate 
inhibition and butyrylcholinesterase is subject to substrate activation. To model these effects, 
equation 23 (Reiner & Simeon-Rudolf 2000) has been used. 
ݒ = ௌܸଵ[ܵ][ܵ] + ܭௌଵ × 1 + ܾ[ܵ]/ܭௌௌଵ1 + [ܵ]/ܭௌௌଵ  (23)
This equation expresses substrate inhibition or activation in the form of a ratio (b) with 
values greater than one indicative of activation and values lower than one indicative of 
inhibition. This equation, while being able to describe the effects of substrate modulation 
fairly well, lacks the ability for easy modification so an alternative equation based on a 
modular expansion of the Michaelis Menten equation was proposed (Equation 24; Walsh et 
al., 2007). 
ݒ = [ܵ][ܵ] + ܭௌଵ ௌܸଵ − [ܵ][ܵ] + ܭௌௌଵ ௌܸଵ + [ܵ][ܵ] + ܭௌௌଵ ௌܸௌଵ (24)
This equation is able to produce very similar results to those of equation 23 but is also 
easily segregated into its components, where the first term relates to reaction rates at 
lower substrate concentrations, the second term is a transition term that segregates the 
form of the enzyme present at lower concentrations from the form present at high 
concentrations and the last term describes the activity of the enzyme at higher substrate 
concentrations. An example of the expansion used in this equation is depicted in Figure 6, 
where a theoretical enzyme is affected initially by substrate activation and then by 
substrate inhibition. 
The modular way in which this equation can be expanded (Equation 25) allows for easy 
integration of modifier terms similar to those found in equation 21 (Walsh et al., 2007). 
ݒ = [ௌ][ௌ]ା௄ೄభ ௌܸଵ − [ௌ][ௌ]ା௄ೄೄభ ௌܸଵ + [ௌ][ௌ]ା௄ೄೄభ ௌܸௌଵ −⋯ [ௌ][ௌ]ା௄ೄ೙షభ ௌܸ௡ିଵ − [ௌ][ௌ]ା௄ೄ೙ ௌܸ௡ିଵ + [ௌ][ௌ]ା௄ೄ೙ ௌܸ௡ (25)
It also demonstrates how the modifier term can also be expanded in a similar modular 
fashion (Equation 26). 
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ௌܸଵ − ሺ ௌܸଵ − ௌܸଶሻ ൬ [ܺ][ܺ] + ܭ௑ଵ൰ + ሺ ௌܸଵ − ௌܸଶሻ ൬ [ܺ][ܺ] + ܭ௑ଶ൰ − ሺ ௌܸଵ − ௌܸଷሻ ൬ [ܺ][ܺ] + ܭ௑ଶ൰ (26)
This term (Equation 26) is almost identical to equation 24 except that there is an initial catalytic 
velocity term (VS1). This rate is altered by the high affinity modifier binding term (KX1), shifting 
the velocity term (VS1) to a new velocity term (VS2). Upon binding of the second modifier 
molecule (KX2) the velocity shift caused by the single binding event (VS2) disappears and the 
new velocity term (VS3) resulting from the presence of two modifiers bound to the enzyme 
replaces it. For example, the modifier homocysteine thiolactone was found to be stimulatory of 
the non-substrate activated form of human butyrylcholinesterase at lower concentrations but 
inhibited the enzyme at higher concentrations (Walsh et al., 2007). 
 
 
 
Fig. 6. Modular partitioning of enzymatic states at different concentrations. The purple 
curve represents the observed enzymatic activity while the other three curves represent the 
relative contribution to the total activity by the different forms of the enzyme. Blue 
represents the enzyme found at low substrate concentration where there is no substrate 
modulation. The red line represents substrate activation produced by secondary substrate 
molecule binding to the enzyme and the green represents inhibition produced by a tertiary 
binding event. Reaction rate is reported as values relative to the maximum activity of the 
enzymatic form not subject to substrate modulation (blue). 
The utility of this sort of modular equation building was further expanded in a paper 
examining the synergistic effects of multiple inhibitors on enzymatic activity (Walsh et al., 
2011b). In this example, two inhibitors of human butyrylcholinesterase were examined for 
their inhibitory effect individually and in combination (Figure 7; Equation 27).  
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Fig. 7. Schematic representation of an enzyme bound by two inhibitors (X and Y), where the 
four quadrants represent the whole enzyme population divided into the inhibitor bound 
fractions that would be present if each inhibitors concentration were equal to its binding 
constant.  
 ௌܸଵ − ሺ ௌܸଵ − ௌܸ௑ሻ ቆቀ [௑][௑]ା௄೉భቁ − ቀ [௑][௑]ା௄೉భቁ ቀ [௒][௒]ା௄ೊభቁቇ −		ሺ ௌܸଵ − ௌܸ௒ሻ ቆቀ [௒][௒]ା௄ೊభቁ − ቀ [௑][௑]ା௄೉భቁ ቀ [௒][௒]ା௄ೊభቁቇ − ሺ ௌܸଵ − ௌܸ௑௒ሻ ቀ [௑][௑]ା௄೉భቁ ቀ [௒][௒]ା௄ೊభቁ  (27) 
Here the inhibitory effect on each catalytic constant was segregated into three effects, the 
effect that each inhibitor had individually and the effect the two inhibitors had together. 
Equation 27 uses the example of the non-substrate activated maximum velocity of the 
enzyme, however the same sort of term was applied to each of the enzymes catalytic 
constants (Equation 24). The first term denotes the effect the first inhibitor (X) has on the 
enzyme (VS1-VSX) multiplied by the percent of the enzyme population bound by the 
inhibitor but subtracting the percent of the population bound by both inhibitors (XY). The 
second term describes the same process but with the other inhibitor (VS1-VSY). The last term 
is the effect produced by both inhibitors binding at the same time (VS1-VSXY). Using this 
strategy, for kinetic equation generation, the effects of galantamine, an inhibitor which 
predominantly inhibits the non-substrate activated form of butyrylcholinesterase, and 
citalopram, an inhibitor of both the non-substrate activated form and the substrate activated 
forms of the enzyme, were modeled individually and together (Rockwood et al., 2011; 
Walsh et al., 2011b). The modeling of this system suggests a possible mechanism for the 
clinical benefit observed in the treatment of Alzheimer's disease when these drugs are 
prescribed together. 
൬ [ܺ][ܺ] + ܭ௑ଵ൰ − ൬ [ܺ][ܺ] + ܭ௑ଵ൰ ൬ [ܻ][ܻ] + ܭ௒ଵ൰ ൬ [ܺ][ܺ] + ܭ௑ଵ൰ ൬ [ܻ][ܻ] + ܭ௒ଵ൰ 
൬ [ܻ][ܻ] + ܭ௒ଵ൰ − ൬ [ܺ][ܺ] + ܭ௑ଵ൰ ൬ [ܻ][ܻ] + ܭ௒ଵ൰ 
www.intechopen.com
 
Medicinal Chemistry and Drug Design 368 
4. Pseudo steady state enzyme kinetic equations in time course modelling of 
substrate hydrolysis 
4.1 First order kinetics  
The decrease in substrate produced by enzymatic catalysis is exponential in nature and can 
be described by the first order chemical reactions (Equation 28). ܣ = ܣ௢݁ି௞௧ (28)
The equation describes the breakdown of substrate using the rate constant (k) and Euler’s 
constant (e) to relate the decrease in substrate concentration (Ao  A) with time (t). Euler’s 
constant raised to the rate constant in this equation represents the fraction of the initial 
reactant present after the first time interval (k1, Equation 29-32).  ܣ = ܣ௢݁ି௞ଵ (29)ܣܣ௢ = ݁ି௞ (30)ܣܣ௢ = ݇ଵ (31)ܣ = ܣ௢݇ଵ௧ (32)
This notation is useful, for it now becomes trivial to define the reduction of substrate in terms 
of the fraction that is converted to product during each time period (1-k2, Equation 33). ܣ = ܣ௢ሺ1 − ݇ଶሻ௧ (33)
This results in a rate of reaction that is defined relative to the initial concentration of the 
reactant (Equation 34).  
 ܣ = ܣ௢ ൬1 − ݒܣ௢൰௧ (34)
This equation can then be used to accommodate the Michaelis-Menten equation, as rates 
associated with the Michaelis-Menten equation exponentially decrease as substrate is 
catalyzed to product (Walsh et al., 2010; Equation 35).  
ܣ = ܣ௢ ൮1 − [ܵ][ܵ] + ܭௌଵ ௌܸଵܣ௢ ൲
௧
 (35)
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The approach was initially used to describe the inhibition of β-galactosidase by imidazole 
using a global kinetic data fitting approach (Walsh et al., 2010). The open structure of the 
expression when compared to integral forms of the Michaelis-Menten equation found in the 
literature allowed for the insertion of modifier terms in the same way outlined in the 
previous section (Walsh et al., 2010; Equation 36). 
ܣ = ܣ௢ ۉۈۈ
ۇ1 − [ܵ][ܵ] + ܭௌଵ − ሺܭௌଵ − ܭௌଶሻ ൬ [ܺ][ܺ] + ܭ௑ଵ൰ ௌܸଵ − ሺ ௌܸଵ − ௌܸଶሻ ൬ [ܺ][ܺ] + ܭ௑ଵ൰ܣ௢ یۋۋ
ۊ௧
 (36)
Additionally, global fitting of this equation to the kinetic data was able to confirm that the 
inhibitor imidazole had an irreversible component to its inhibition of β-galactosidase (Kim 
et al., 2003) as the simple insertion of modifier terms into equation 35 was unable to 
describe the effect of the inhibitor on the enzyme. While the hydrolysis of substrate 
tended towards zero in the absence of imidazole, the introduction of the inhibitor stopped 
the enzymatic activity in a concentration dependent manner. Therefore it was reasoned 
that a certain fraction of the inhibitor bound enzyme population was inactivated by this 
process (Equation 37).  
݇௔ [ܺ][ܺ] + ܭ௑ଵ (37)
Therefore a ratio term, defining the ratio between the rate of enzyme irreversible inhibition 
and the rate of substrate hydrolysis was used to define the fraction of the substrate 
population that would be hydrolysed before complete enzyme inactivation occurred 
(Equation 38). An additional term defining the substrate that would persist after the enzyme 
was also defined (Equation 39). In these terms, equation 21 has been represented as v for 
simplicity. 
 
ܣ௢ ൮ ݒܣ௢ݒܣ௢ + ݇௔ [ܺ][ܺ] + ܭ௑ଵ൲ (38)
ܣ௢ ൮ ݇௔ [ܺ][ܺ] + ܭ௑ଵݒܣ௢ + ݇௔ [ܺ][ܺ] + ܭ௑ଵ൲ (39)
 
Inserting these terms into equation 36 produced an equation that was able to model the 
decrease in substrate concentration with time and take into account the irreversible 
inhibitory effects of imidazole on  β-galactosidase (Walsh et al., 2010; Equation 40).  
www.intechopen.com
 
Medicinal Chemistry and Drug Design 370 
ܣ = ܣ௢ ൮ ݒܣ௢ݒܣ௢ + ݇௔ [ܺ][ܺ] + ܭ௑ଵ൲ۉۈ
ۈۈۈۇ1 − ݒܣ௢൮ ݒܣ௢ݒܣ௢ + ݇௔ [ܺ][ܺ] + ܭ௑ଵ൲یۋ
ۋۋۋۊ
௧
+ ܣ௢൮ ݇௔ [ܺ][ܺ] + ܭ௑ଵݒܣ௢ + ݇௔ [ܺ][ܺ] + ܭ௑ଵ൲ (40)
5. Conclusions 
5.1 Modular enzyme kinetic equations  
The modular method of equation generation discussed here does not necessarily require 
derivation from initial conservation of mass and rate equations that were used in the 
generation of classical pseudo steady state enzyme kinetic equations. Rather, by clearly 
distinguishing between the mass action binding terms and the governor terms, which 
describe the kinetic effect of modifiers, a general method to characterize the effect of 
inhibitors and activators on enzymatic activity is suggested (Equation 21). The structure of 
this modified version of the Michaelis Menten equation allows for its modular expansion to 
describe multiple substrate binding interactions (Equation 24), multiple modifier binding 
interactions (Equation 26) and the effects of more than one modifier binding to the same 
enzyme (Equation 27). The modular way in which these equations can be expanded to 
describe the bulk kinetic properties associated with enzyme kinetic modeling suggests that 
they may neglect processes such as modifier and substrate binding order. However there are 
several possibilities which may result from such processes. For example, an inhibitor may 
bind to an enzyme only in the absence of the substrate or only in its presence, in both of 
these instances the inhibition would most likely manifest as a rectangular hyperbolic change 
in the catalytic constants influencing enzymatic activity. Alternatively if the inhibitor binds 
both forms of the enzyme, the affinity for each form may be quite different resulting in a 
term similar to that proposed with equation 26. While there are undoubtedly many more 
possibilities, as have been outlined in texts such as Enzyme Kinetics by Segel (1993), the 
derivation of these equations have neglected the division between mass binding and 
modifier effect proposed here.  
This distinction between mass binding and modifier effect combined with the modular 
equation construction described herein represents a new way of addressing enzyme kinetic 
modelling which permits the simple adaptation of kinetic models for data analysis. This 
allows for a simplified comparative global data fitting to discriminate between competing 
kinetic models using nonlinear regression. A helpful guide to nonlinear data fitting in excel 
has recently been published in Nature Protocols (Kemmer & Keller, 2010). 
5.2 Pseudo-steady state equations in time course modeling 
Integral forms of the Michaelis Menten equation have been proposed for use in time course 
analysis for many years, with more complex mathematical models appearing with time 
(Russell & Drane, 1992; Goudar et al., 1999). Integral forms of the Michaelis Menten 
equation however have been found to be limited in their usefulness for time course models 
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which has spurred further research (Liao et al., 2005). Integral forms of the Michaelis 
Menten equation also predominately model the Michaelis Menten equation and do not deal 
with modifier interactions. This may be in part due to the problems associated with pseudo-
steady state modifier equations, such as lack of governor terms on the effects of modifiers in 
enzyme systems, as outlined in the first section of this chapter. To attempt to address these 
issues a new way of using pseudo-steady state equations in time course modeling has been 
proposed (Walsh et al., 2010). The proposed methodology inserts the pseudo-steady state 
equations directly into the exponential decay equation (Equation 35) allowing for the same 
degree of equation flexibility outlined with the methods for modular expansion of pseudo-
steady state equations described in section 3.2.  
The direct use of so called pseudo-steady state equations in exponential equations relies on 
several assumptions. Primarily, the development of pseudo-steady state equations has been 
based on experimental data generated in closed systems. That is, even if preformed in 
conditions where the rate of substrate hydrolysis is taken as linear or is linearized through 
the use of tangential slope lines, the observed rates are actually exponentially decreasing. 
Additionally, single substrate enzymes, which are not subject to conditions that would alter 
their catalytic activity, such as substrate or product modulation, as catalysts follow first 
order kinetics in closed systems (Equation 35). Due to this, time course modeling has the 
advantage of being able to identify a variety of kinetic situations, such as strong substrate 
activation or inhibition, for which initial rate analysis is not optimal (Shushanyan et.al., 
2011). This sort of modeling can also be used to detect the influence of irreversible inhibition 
as deviation of the exponential curve away from the predicted initial exponential rate in 
substrate hydrolysis are more apparent with time course models than models using initial 
rates.  For example, in our initial examination of the inhibition of β-galactosidase with 
imidazole with initial rates the irreversible inhibition of β-galactosidase was not apparent 
(Walsh et al., 2007), however it became quite apparent using time course models (Walsh et 
al., 2010). 
The ease with which this method allows the integration of pseudo-steady state and time 
course kinetic equations holds the promise of making time course kinetic modeling a more 
prominent part of modifier kinetic analysis. Additionally, the modular compilation of 
kinetic components outlined in this chapter and their application to time course modeling 
suggest this form of modeling may be particularly useful for in-depth characterization of 
enzymatically regulated pathways which is directly applicable to systems biology. 
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